In the conclusion of a two-part interview, Lokesh Ohri, Americas consumer consulting leader and a principal at EY, talks about major retailers’ use of technology and their growing scope in health care and media. He addresses the metaverse and its potential impact, personalization, and the balance between in-store shopping and e-commerce.
Video Forum: Lokesh Ohri, EY, Part 2
In the conclusion of a two-part interview, Lokesh Ohri, Americas consumer consulting leader and a principal at EY, talks about major retailers’ use of technology and their growing scope in health care and media.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
Washington, D.C. man in the running for the Most Benevolent Beard in America
Now in its fourth year, the contest is part of the grooming company's ongoing mission to recognize and reward those who embody their philosophy of making the world a better – or 'bearder' – place to live.
Video Forum: April Showers, Afro Unicorn
A lifestyle brand for women and children of color.
Reimagining drug stores as gateways to wellness
By Rachel Tetreault, general manager for omnichannel health care at Market Performance Group
Cencora settles suit over alleged opioid mismanagement
The lawsuit brought by pension funds accused Cencora’s leadership of ignoring red flags around how the company was dispensing the highly addictive painkillers for years — including dubiously large opioid shipments — and failing to properly monitor opioid sales.